Delivery Order SPE2DB20D3103-SPE2DB25FP0A9
- Not listed
- The Defense Logistics Agency awarded a $1,817.31 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine medical supply procurement under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,155.97 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,498.25 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This firm fixed price contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order...
- The Defense Logistics Agency awarded a delivery order valued at $2,458.34 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers. The contract is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's broader pharmaceutical supply agreement with DLA. This award was issued on July 10, 2025, with an ultimate completion date of July 11, 2025, and will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,853.12 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. This non-competed delivery order, issued on June 16, 2025, with a completion date of June 17, 2025, is structured as a firm fixed-price contract for pharmaceutical supply to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $2,436.13 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This contract, issued on August 25, 2025, with completion scheduled for August 26, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This is a firm fixed-price, non-set-aside contract with a ceiling value of $1,051.91 and an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,955.90 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of June 27, 2025, one day after the award date. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a critical pharmaceutical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP0A9Delivery Order
The Defense Logistics Agency awarded a $4,436.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, regularly fulfills medical supply needs for military and veteran healthcare systems through its extensive DLA contract portfolio. The Fluticasone Propionate inhalers represent a respiratory medication delivery under the company's broader mandate to supply brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities across multiple therapeutic domains. As the prime contractor on this delivery order, AmerisourceBergen demonstrates its continued role as a key supplier within the Defense Health Agency's pharmaceutical supply chain, supporting the military healthcare system's operational requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 5/30/25 |